Predicting kidney function from amniotic fluid in babies with kidney issues
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study uses a sample of the fluid around your baby (amniotic fluid) to try to predict how well their kidneys will work after birth. It is for pregnancies where both kidneys have been found to have a structure problem.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The baby must have problems with both kidneys (not just one) that are seen on ultrasound.
- You must be having an amniocentesis (a test to collect fluid around the baby).
- This trial is for single pregnancies only (no twins).
- You must give signed permission (informed consent) and the father must not object.
- You cannot be under legal protection (like guardianship).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks the health of women with kidney problems before, during, and after pregnancy to learn how to better care for them. It is for women who have had kidney disease, high blood pressure, certain pregnancy complications, or a kidney transplant.
This study tests a new way to predict early kidney problems in newborns staying in the NICU. It looks at babies’ health information to see if the STARZ score helps doctors find kidney injury sooner.
This study offers free urine and ultrasound screening for kidney disease in all newborn infants, with a goal to find and track potential issues early over the first 3 years of life.
This study checks whether a specific kidney test (a renogram scan) can detect a significant urine blockage early in babies born with ureter-pelvic junction obstruction (a narrow connection between the kidney and ureter). It may help clinicians decide sooner which babies need closer follow-up or treatment.
This study looks at the genetic material in the fluid around the baby (amniotic fluid) and in the placenta to better understand complex heart defects in unborn babies. The goal is to find new clues that could help doctors care for these babies before and after birth.
This trial is testing whether adding fluid back into the womb (amnioinfusion) can help babies whose kidneys are not working and who have no amniotic fluid early in pregnancy. It may improve the baby's chances of survival and lung development.
Hear when a new Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.